These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19211579)

  • 21. Activated protein C resistance assay and factor V Leiden.
    Prüller F; Weiss EC; Raggam RB; Cervar-Zivkovic M; Renner W; Wagner J; Michaelis S; März W; Mangge H
    N Engl J Med; 2014 Aug; 371(7):685-6. PubMed ID: 25119624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central retinal artery occlusion in a patient homozygous for factor V Leiden.
    Larsson J
    Am J Ophthalmol; 2000 Jun; 129(6):816-7. PubMed ID: 10927002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the factor V Leiden mutation (resistance to activated protein C).
    Glueck CJ; Wang P; Fontaine RN; Tracy T; Sieve-Smith L; Lang JE
    Am J Cardiol; 1999 Sep; 84(5):549-54. PubMed ID: 10482153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arterial vascular occlusion associated with factor V Leiden gene mutation.
    Tayyanipour R; Pulido JS; Postel EA; Lipkowitz JL; Pisciotta A; Braza E
    Retina; 1998; 18(4):376-7. PubMed ID: 9730184
    [No Abstract]   [Full Text] [Related]  

  • 25. Risk of thrombosis with anomalies of the inferior vena cava and factor V Leiden.
    Sánchez Fernández GL; Reiss UM; de Alarcón PA
    Pediatr Blood Cancer; 2008 Mar; 50(3):731. PubMed ID: 17514740
    [No Abstract]   [Full Text] [Related]  

  • 26. Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithm.
    Van Cott EM; Soderberg BL; Laposata M
    Arch Pathol Lab Med; 2002 May; 126(5):577-82. PubMed ID: 11958664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Is lifetime anticoagulation required in factor V Leiden mutation?].
    Pötzsch B
    Dtsch Med Wochenschr; 2003 Jul; 128(30):1617. PubMed ID: 12884152
    [No Abstract]   [Full Text] [Related]  

  • 28. The prevalence of factor V Arg306-->Thr (factor V Cambridge) and factor V Arg306-->Gly mutations in different human populations.
    Franco RF; Elion J; Tavella MH; Santos SE; Zago MA
    Thromb Haemost; 1999 Feb; 81(2):312-3. PubMed ID: 10064012
    [No Abstract]   [Full Text] [Related]  

  • 29. Activated protein C resistance (FV(Leiden)) and thrombosis: factor V mutations causing hypercoagulable states.
    Nicolaes GA; Dahlbäck B
    Hematol Oncol Clin North Am; 2003 Feb; 17(1):37-61, vi. PubMed ID: 12627662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor V Leiden and venous thrombosis in a 4-yr-old girl with Behçet's syndrome.
    Ihle J; Kümmerle-Deschner J; Orlikowsky T; Albert E; Niethammer D; Dannecker GE
    Rheumatology (Oxford); 2000 Feb; 39(2):209-10. PubMed ID: 10725075
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of factor V Leiden mutation in Yugoslav thrombophilic patients and its relationship to the laboratory diagnosis of APC resistance.
    Mikovic D; Rakicevic L; Kovac M; Radojkovic D
    Thromb Haemost; 2000 Oct; 84(4):723-4. PubMed ID: 11057877
    [No Abstract]   [Full Text] [Related]  

  • 32. Heterogeneity of activated protein C resistance phenotype in subjects with compound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V gene.
    Castaman G; Ruggeri M; Tosetto A; Rodeghiero F
    Thromb Haemost; 2000 Aug; 84(2):357-8. PubMed ID: 10959717
    [No Abstract]   [Full Text] [Related]  

  • 33. Activated protein C resistance and factor V Leiden in Mexico.
    Majluf-Cruz A; Moreno-Hernández M; Ruiz-de-Chávez-Ochoa A; Monroy-García R; Majluf-Cruz K; Guardado-Mendoza R; Molina-Avila I; Isordia-Salas I; Corona-de la Peña N; Vargas-Vorackova F; Vela-Ojeda J; García-Chávez J
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):428-37. PubMed ID: 18160617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bilateral retinal vein occlusion associated with factor V Leiden mutation.
    Spagnolo BV; Nasrallah FP
    Retina; 1998; 18(4):377-8. PubMed ID: 9730185
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative analysis of "APTT vs RVVT" based activated protein C resistance assay in the diagnosis of Factor V Leiden mutation.
    Baig MA
    Indian J Pathol Microbiol; 2020; 63(2):247-250. PubMed ID: 32317524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The incidence of factor V Leiden in a normal Irish population and its relationship to the laboratory diagnosis of APC resistance.
    Vaughan J; Power C; Nolan C; McCarthy D; Shirley I
    Thromb Haemost; 1999 Apr; 81(4):661-3. PubMed ID: 10235460
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mutation of factor V Leiden and chronic leg edema with chronic venous insufficiency and recurrent thromboses].
    Chanda RA
    Praxis (Bern 1994); 1999 Sep; 88(36):1449-50. PubMed ID: 10500421
    [No Abstract]   [Full Text] [Related]  

  • 38. Double heterozygosity for Factor V Leiden and Factor V Cambridge mutations associated with low levels of activated protein C resistance in a Spanish thrombophilic family.
    Santamaría A; Soria JM; Tirado I; Mateo J; Coll I; Souto JC; Fontcuberta J
    Thromb Haemost; 2005 Jun; 93(6):1193-5. PubMed ID: 15968408
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prevalence of the activated protein C resistance in indigenous and Black populations of the western Venezuela].
    Vizcaíno G; Torres E; Quintero J; Herrmann F; Grimm R; Diez-Ewald M; Arteaga-Vizcaíno M; Pérez-Requejo JL; Colina-Araujo J
    Invest Clin; 2000 Mar; 41(1):29-36. PubMed ID: 10758697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss.
    Younis JS; Brenner B; Ohel G; Tal J; Lanir N; Ben-Ami M
    Am J Reprod Immunol; 2000 Jan; 43(1):31-5. PubMed ID: 10698038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.